Strain rate, temperature and deformation state effect on Ecoflex 00-50 silicone mechanical behaviour

Silicone elastomers are extremely attractive materials due to their wide range of possible applications, from biomedical engineering to soft robotics. In this work, an extensive thermo-mechanical characterization of Ecoflex Shore hardness 00–50, a commercially available silicone elastomer, has been carried out to compensate for the lack of relevant literature. The mechanical behaviour of the material has been characterized by performing monotonic and cyclic loading tests. These tests were performed in different deformation states, i.e. uniaxial tension, pure shear and biaxial tension, at different strain rates and temperatures. Experimental findings allowed to highlight the material time-dependent response and quantify the contribution of dissipative deformation phenomena to the overall strain energy. Uniaxial tensile tests performed at different temperatures (between −40 °C and 140 °C) showed that the material mechanical behaviour is sensitive to temperature in this range: a decrease of the ultimate stress and strain has been observed with increasing temperature. Finally, the data obtained from the latter tests have been used to define a failure envelope, applied for the first time to Ecoflex silicones, and valuable to describe the material ultimate stress and strain at any temperature and strain rate

Preslaughter Mortality in Broiler Chickens, Turkeys, and Spent Hens Under Commercial Slaughtering

Abstract The incidence of dead on arrival (DOA) birds was surveyed over 33 broiler, 11 turkey, and 19 spent hen abattoirs representing the majority (around 70%) of the Italian poultry slaughter plants. Data were recorded monthly during a 4-yr period (August 2001 to July 2005), considering a total of 1,266 million chicken broilers, 118 million turkeys, and 54 million spent hens, which represent 67.7, 84.0, and 28.4% of the national production, respectively. The overall average incidence of DOA was found to be 0.35, 0.38, and 1.22% in broilers, turkeys, and spent hens, respectively. The season significantly (P ≤ 0.01) influenced the mortality of all considered poultry categories, with higher incidence being observed during the summer (0.47, 0.52, and 1.62% for broilers, turkeys, and spent layers, respectively). The incidence of DOA broilers was found to be lower in small slaughter plants compared with medium and large slaughter plants (0.28 vs. 0.38 and 0.35%, P ≤ 0.01). The data obtained in this study might be used for establishing limit values of DOA as a welfare indicator during the preslaughter time of birds, including catching, loading, transportation, and lairage

Host range of mammalian orthoreovirus type 3 widening to alpine chamois

Mammalian orthoreoviruses (MRV) type 3 have been recently identified in human and several animal hosts, highlighting the apparent lack of species barriers. Here we report the identification and genetic characterization of MRVs strains in alpine chamois, one of the most abundant wild ungulate in the Alps. Serological survey was also performed by MRV neutralization test in chamois population during five consecutive years (2008-2012). Three novel MRVs were isolated on cell culture from chamois lung tissues. No respiratory or other clinical symptoms neither lung macroscopic lesions were observed in the chamois population. MRV strains were classified as MRV-3 within the lineage III, based on S1 phylogeny, and were closely related to Italian strains identified in dog, bat and diarrheic pig. The full genome sequence was obtained by next-generation sequencing and phylogenetic analyses showed that other segments were more similar to MRVs of different geographic locations, serotypes and hosts, including human, highlighting genome reassortment and lack of host specific barriers. By using serum neutralization test, a high prevalence of MRV-3 antibodies was observed in chamois population throughout the monitored period, showing an endemic level of infection and suggesting a self-maintenance of MRV and/or a continuous spill-over of infection from other animal species

The GOODSTEP project: General Object-Oriented Database for Software Engineering Processes

The goal of the GOODSTEP project is to enhance and improve the functionality of a fully object-oriented database management system to yield a platform suited for applications such as software development environments (SDEs). The baseline of the project is the O2 database management system (DBMS). The O2 DBMS already includes many of the features regulated by SDEs. The project has identified enhancements to O2 in order to make it a real software engineering DBMS. These enhancements are essentially upgrades of the existing O2 functionality, and hence require relatively easy extensions to the O2 system. They have been developed in the early stages of the project and are now exploited and validated by a number of software engineering tools built on top of the enhanced O2 DBMS. To ease tool construction, the GOODSTEP platform encompasses tool generation capabilities which allow for generation of integrated graphical and textual tools from high-level specifications. In addition, the GOODSTEP platform provides a software process toolset which enables modeling, analysis and enaction of software processes and is also built on top of the extended O2 database. The GOODSTEP platform is to be validated using two CASE studies carried out to develop an airline application and a business application

An outbreak of viral gastroenteritis linked to municipal water supply, Lombardy, Italy, June 2009

n/

Genetic heterogeneity of porcine enteric caliciviruses identified from diarrhoeic piglets

Enteric caliciviruses (noroviruses and sapoviruses) are responsible for the majority of non-bacterial gastroenteritis in humans of all age groups. Analysis of the polymerase and capsid genes has provided evidence for a huge genetic diversity, but the understanding of their ecology is limited. In this study, we investigated the presence of porcine enteric caliciviruses in the faeces of piglets with diarrhoea. A total of 209 samples from 118 herds were analyszd and calicivirus RNA was detected by RT-PCR in 68 sample (32.5%) and in 46 herds (38.9%), alone or in mixed infection with group A and C rotaviruses. Sequence and phylogenetic analysis of the calicivirus-positive samples characterized the majority as genogroup III (GGIII) sapoviruses. Unclassified caliciviruses, distantly related to the representatives of the other sapovirus genogroups, were identified in five herds, while one outbreak was associated with a porcine sapovirus related genetically to human GGII and GGIV sapovirus strains. By converse, norovirus strains were not detected. Altogether, these data suggest the epidemiological relevance of porcine enteric caliciviruses and suggest a role in the etiology of piglets diarrhoe

Massive proliferative cutaneous lesions associated with Poxviridae and Papillomaviridaeviral species in ruminants

n/

Fast and real-time electrical transistor assay for quantifying SARS-CoV-2 neutralizing antibodies

Due to the SARS-CoV-2 pandemic renewed attention has been directed towards viral neutralization assays and neutralizing antibodies quantification, for vaccine pre-clinical trials and determining vaccine efficacy over time. The gold standard to assess antibody titer is the plaque reduction neutralization test, an end-point assay which evaluates the highest serum antibody dilution that neutralizes viral replication, by inspecting the cytopathic effect induced on cell cultures. Here, we use planar, PEDOT:PSS-based organic electrochemical transistors for real-time, remote-controlled, reliable and fast electrical monitoring of the cytopathic effect induced by SARS29 CoV-2 on Vero E6 cell lines, allowing the quantification of serum neutralizing titer. Our low-cost and scalable device has the potential to speed-up large-scale viral neutralization screening without the need for cancerous staining or highly specialized operators. Finally, the technology could be easily transferred to assess neutralizing antibody response towards different viruses in their permissive cell substrates

A Conceptual Basis for Feature Engineering

The gulf between the user and the developer perspectives lead to diculties in producing successful software systems. Users are focused on the problem domain, where the system's features are the primary concern. Developers are focused on the solution domain, where the system's life-cycle artifacts are key. Presently, there is little understanding of how to narrow this gulf

Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product

Background: A growing number of clinical trials have shown that regulatory T (Treg) cell transfer may have a favorable effect on the maintenance of self-tolerance and immune homeostasis in different conditions such as graft-versus-host disease (GvHD), solid organ transplantation, type 1 diabetes, and others. In this context, the availability of a robust manufacturing protocol that is able to produce a sufficient number of functional Treg cells represents a fundamental prerequisite for the success of a cell therapy clinical protocol. However, extended workflow guidelines for nonprofit manufacturers are currently lacking. Despite the fact that different successful manufacturing procedures and cell products with excellent safety profiles have been reported from early clinical trials, the selection and expansion protocols for Treg cells vary a lot. The objective of this study was to validate a Good Manufacturing Practice (GMP)-compliant protocol for the production of Treg cells that approaches the whole process with a risk-management methodology, from process design to completion of final product development. High emphasis was given to the description of the quality control (QC) methodologies used for the in-process and release tests (sterility, endotoxin test, mycoplasma, and immunophenotype). Results: The GMP-compliant protocol defined in this work allows at least 4.11 7 109 Treg cells to be obtained with an average purity of 95.75 \ub1 4.38% and can be used in different clinical settings to exploit Treg cell immunomodulatory function. Conclusions: These results could be of great use for facilities implementing GMP-compliant cell therapy protocols of these cells for different conditions aimed at restoring the Treg cell number and function, which may slow the progression of certain diseases